Last updated 2026-07-20
- Acquired by RxE2, Jan 2021
- Raised Pre-Seed round led by t-syte, Mar 2020
Total raised
—
Last: Undisclosed Round 2020-04
Stage
Acquired
Founded
2020
Headcount
1-10
HQ
Herzliya, Israel
Sector
Health Tech & Life Sciences
About
Habitu is an AI-based platform for clinical trial remote patient monitoring and data management. It provides an interactive communication platform for clinical trial patients to communicate with experts. The platform uses AI to track patient behavior, analyze data, provide behavioral predictions, analytics, and alerts for healthcare interventions.
Funding history · 1 round · — total
2020-03
Pre-Seed
Undisclosed
★ t-syte
Headcount over time
From 5 (2020-04) to 6 (2021-01) · +1 (+20%) · 2 points · source: Finder history + radar grounding
Q&A
- What is Habitu's primary business?
- Habitu develops an interactive communication platform aimed at informing, engaging, tracking, and personalizing the patient experience in decentralized environments like home hospitalization and clinical trials.
- When was Habitu acquired and by whom?
- Habitu was acquired by RxE2 in January 2021.
- Where is Habitu's headquarters located?
- Habitu's headquarters is located in Herzliya, Center District, Israel.
- When was Habitu founded?
- Habitu was founded in November 2018.
- Which sector does Habitu primarily operate in?
- Habitu's primary sector is Health Tech & Life Sciences.
- What technologies does Habitu utilize in its platform?
- Habitu's platform incorporates Platforms & Interfaces, Mobile technology, and Artificial Intelligence.
- Who are the target customers for Habitu's platform?
- Habitu targets customers in Healthcare & Life Sciences, specifically Life Sciences, Pharmaceuticals, Healthcare, Patients, and Providers.
Team · 1
Yaniv Zilberman
Founder · Co-Founder & CEO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcarePatient Engagement
Technologies
Platforms & InterfacesMobileArtificial Intelligence
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatientsProviders
Business model
B2B2C
Tags
chronic-patientsrecommendationsdigital-healthcaremobile-applicationsclinical-trialspatient-engagementfamilypatientspharma-companiesvideopersonalizationadherencemedicationartificial-intelligenceactionable-insights
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/18543012 |
Identifiers & details
| Former names | Fore Trial |
|---|---|
| Founded | 2020 |
| Status reason | Acquired (Inactive) by RxE2 on Jan 2021 - closed due to acquisition |
Acquisitions & public offerings
Acquired by RxE2 2021-01
Radar intelligence
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515929164 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2018-11-20 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 2 — annual_report (2) |
| Registered address | זמיר 13 הוד השרון |
Recent registry events
| Date | Event |
|---|---|
| 2025-07-28 | דו~ח שנתי-הסרת בעל תפקיד |
| 2025-07-28 | דו~ח שנתי-הוספת בעל תפקיד |